Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Dr. John Prensner, M.D., Ph.D. – University of Michigan Medical Center (Michigan Medicine), Ann Arbor, MI
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
Trustees of Dartmouth College, Lebanon, NH